Kidney shrinkage

An abnormal phenomenon that is relatively small or significantly reduced according to the comparison of kidney volume with human age, gender, and human height and weight. Prolonged kidney disease results in damage to the nephrons, especially the glomeruli, and shrinks the entire kidney. Renal shrinkage Renal shrinkage should be considered as renal atrophy and renal vascular disease with congenital renal dysplasia or end-stage renal disease. Renal atrophy can be seen in congenital renal dysgenesis with collagen and calcium deposits or some acute lesions, such as: acute glomerular disease, diabetic nephroplasia, renal transplant rejection, chronic glomerulonephritis, renal cortex Necrosis, Alport syndrome, acute tubular necrosis, hypertensive renal sclerosis. Focal or diffuse renal parenchymal destruction is seen in any mass lesions (such as cysts, tumors, abscesses, and hematomas), focal pyelonephritis, parenchymal scars (such as renal infarction or atrophic pyelonephritis), and infantile types Cystic kidney, chronic pyelonephritis or lesions. Renal atrophy caused by renal vascular disease can be caused by the following diseases: endometrial disease, trauma, malignant disease, or embolism due to heart disease. Renal atrophy is a pathological and anatomical term, which means that the kidney is atrophic and the volume is significantly reduced. It is also called end-stage kidney. At this time, most or all of the glomerular tubules (ie nephrons) have been destroyed, and the kidneys have lost their physiological functions.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.